2-Hydroxypropyl methacrylate was studied for its oral toxicity in rats in an OECD combined repeat dose and reproductive/developmental toxicity screening test at doses of 0, 30, 100, 300 and 1000 mg/kg/day. With regard to repeat dose toxicity, for the males, salivation, decreases in locomotor activity, ptosis, hematocrit, RBC and hemoglobin and an increase in the relative liver weight were seen at 1000 mg/kg, and 2 of the 12 animals died. For the females, salivation, decreases in locomotor activity and ptosis were seen at 1000 mg/kg, and 1 of the 12 animals died. The NOEL for repeat dose toxicity is considered to be 300 mg/kg for both sexes. With regard to reproductive/developmental toxicity, no effects of the test substance on copulation, fertility, delivery as lactation were noted. The NOELs for reproductive performance of males and females, and for pup development are considered to be 1000 mg/kg/day for both sexes.
2-Hydroxypropyl methacrylate was not mutagenic to Salmonella typhimurium TA100, TA98, TA1535, TA1537 and Escherichia coli WP2 uvrA, with or without an exogeneous metabolic activation system.
2-Hydroxypropyl methacrylate induced structural chromosomal aberrations in CHL/IU cells with and without an exogeneous metabolic activation system. Polyploidy was induced without an exogeneous metabolic activation system.
Purity | : | 98% |
Test species/strain | : | Rat/Crj:CD (SD) |
Test method | : | OECD Guidelines 401 |
Route | : | Oral (gavage) |
Doses | : | 0 (vehicle), 500, 1000, 2000 mg/kg |
Number of animals/group | : | Males, 5 ; females, 5 |
Vehicle | : | Water for injection |
GLP | : | Yes |
Test results:
Purity | : | 98% |
Test species/strain | : | Rat/Crj:CD (SD) |
Test method | : | OECD Combined Repeat Dose and Reproductive/Developmental Toxicity Screening Test |
Route | : | Oral (gavage) |
Doses | : | 0 (vehicle), 30, 100, 300, 1000 mg/kg/day |
Number of animals/group | : | Males, 12 ; females, 12 |
Vehicle | : | Water for injection |
Administration period | : | Males, 49 days
Females, from 14 days before mating to day 3 of lactation |
Terminal kill | : | Males, day 50 Females, day 4 of lactation |
GLP | : | Yes |
Test results:
Purity | : | 98% |
Test species/strains | : | S.typhimurium TA100, TA1535, TA98, TA1537, Escherichia coli WP2 uvrA |
Test methods | : | Guidelines for Screening Mutagenicity Testing of Chemicals (Japan) and OECD (471 and 472) |
Procedures | : | Plate incorporation method |
Solvent | : | Acetone |
Positive controls | : | -S9 mix, 2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide (TA100, WP2, TA98), Sodium azide (TA1535) and 9-Aminoacridine (TA1537), +S9 mix, 2-Aminoanthracene (five strains) |
Dosage | : | 0, 313, 625, 1250, 2500 and 5000 μg/plate in five strains, -S9 mix and +S9 mix |
S9 | : | Rat liver, induced with phenobarbital and 5,6-benzoflavone |
Plates/test | : | 3 |
Number of replicates | : | 2 |
GLP | : | Yes |
Test results:
+ | ? | - | |
without metabolic activation | [ ] | [ ] | [*] |
with metabolic activation | [ ] | [ ] | [*] |
+ | ? | - | |
without metabolic activation | [ ] | [ ] | [*] |
with metabolic activation | [ ] | [ ] | [*] |
Purity | : | 98% |
Type of cell used | : | Chinese hamster lung (CHL/IU) cells |
Test method | : | Guidelines for Screening Mutagenicity Testing of Chemicals (Japan) |
Solvent | : | Acetone |
Positive controls | : | -S9 mix, Mitomycin C +S9 mix, Cyclophosphamide |
Doses | : | -S9 mix (continuous treatment): 0, 0.18, 0.35, 0.70 mg/ml -S9 mix (short-term treatment): 0, 0.35, 0.70, 1.4 mg/ml +S9 mix (short-term treatment): 0, 0.35, 0.70, 1.4 mg/ml |
S-9 | : | Rat liver, induced with phenobarbital and 5,6-benzoflavone |
Plates/test | : | 2 |
GLP | : | Yes |
Test results:
Without metabolic activation (continuous treatment) | : | 0.35 mg/ml (clastogenicity) 0.18 mg/ml (polyploidy) |
Without metabolic activation (short-term treatment) | : | 1.4 mg/ml (clastogenicity) |
With metabolic activation (short-term treatment) | : | 0.35 mg/ml (clastogenicity and polyploidy) |
clastogenicity | polyploidy | |||||
+ | ? | - | + | ? | - | |
without metabolic activation: | [*] | [ ] | [ ] | [*] | [ ] | [ ] |
with metabolic activation: | [*] | [ ] | [ ] | [ ] | [*] | [ ] |
1) | The test was performed by Nihon Bioresearch Inc. Hashima Laboratory, 6-104 Majima, Fukuju-cho, Hashima, Gifu, 501-62 Japan Tel +81-58-392-6222 Fax +81-58-391-3171 |
2) | The tests were performed by the Hatano Research Institute, Food and Drug Safety Center, 729-5 Ochiai, Hadano-shi, Kanagawa, 257, Japan. Tel +81-463-82-4751 Fax +81-463-82-9627 |